(OPCH) Option Care Health - Ratings and Ratios
Infusion, Therapy, Nutrition, Treatment, Services
OPCH EPS (Earnings per Share)
OPCH Revenue
Description: OPCH Option Care Health
Option Care Health Inc (NASDAQ:OPCH) is a leading provider of home and alternate site infusion services services in the United States, delivering a broad range of infusion therapies and related services to patients patients with various acute and chronic conditions. The companys comprehensive services encompass anti-infect-therapy, parenteral nutrition nutrition, immunoglobulin therapy, and treatments treatments for inflammatory disorders, neurological as well as neurological disorders. Additionally, Option Care Health offers infusion therapies for bleeding bleeding disorders, high-risk pregnancy, pain management, and oncology, alongside nursing services.services. With a strong presence in the the US healthcare market, the company leverages referrals from physicians, hospital discharge planners, and health organizations to drive growth.
From a financial perspective, Option Option Care Health has demonstrated stability, boasting a market capitalization of approximately $5.35 billion. The stock has shown a relatively stable performance, recent months, trading around $31.90, with a 20-day moving average of $32.14 and a 50-day moving average of $32.61.61. Given the current technical indicators, including an ATR of 1.06 (3.31% volatility), and fundamental metrics such as a a P/E ratio of 26.02 and an RoE of 15.29%, a plausible forecast is that the stock stock OPCH may experience a moderate uptrend, potentially reaching $35.20 within the next 6-12 months, driven by the companys strong market position and the growing demand for demand for home infusion services.
Based on the analysis of both technical and fundamental fundamental data, it is reasonable to reasonable to anticipate that OPCH will continue to exhibit a stable growth trajectory. The companys diversified service offerings, combined with its established market presence, are likely to contribute positively to its financial performance. As the healthcare industry continues to evolve, Option Care Care Healths focus on home and alternate site site infusion services is well-positioned to position to capitalize on emerging trends trends and opportunities.
Additional Sources for OPCH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
OPCH Stock Overview
Market Cap in USD | 5,319m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1996-08-15 |
OPCH Stock Ratings
Growth Rating | 66.2 |
Fundamental | 57.3 |
Dividend Rating | 0.0 |
Rel. Strength | 10.6 |
Analysts | 4.5 of 5 |
Fair Price Momentum | 30.93 USD |
Fair Price DCF | 44.25 USD |
OPCH Dividends
Currently no dividends paidOPCH Growth Ratios
Growth Correlation 3m | -44.6% |
Growth Correlation 12m | 45.2% |
Growth Correlation 5y | 70.7% |
CAGR 5y | 18.30% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | 0.64 |
Alpha | -3.37 |
Beta | 0.253 |
Volatility | 31.18% |
Current Volume | 1042k |
Average Volume 20d | 1323.7k |
Stop Loss | 28.8 (-3.6%) |
As of July 12, 2025, the stock is trading at USD 29.88 with a total of 1,042,047 shares traded.
Over the past week, the price has changed by -3.33%, over one month by -5.71%, over three months by -5.29% and over the past year by +3.18%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Option Care Health (NASDAQ:OPCH) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.33 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OPCH is around 30.93 USD . This means that OPCH is currently overvalued and has a potential downside of 3.51%.
Option Care Health has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy OPCH.
- Strong Buy: 6
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, OPCH Option Care Health will be worth about 33.6 in July 2026. The stock is currently trading at 29.88. This means that the stock has a potential upside of +12.45%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 38.6 | 29% |
Analysts Target Price | 38.6 | 29% |
ValueRay Target Price | 33.6 | 12.4% |